Zinc in PDB 1oxn: Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap)
Protein crystallography data
The structure of Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap), PDB code: 1oxn
was solved by
M.C.Franklin,
S.Kadkhodayan,
H.Ackerly,
D.Alexandru,
M.D.Distefano,
L.O.Elliott,
J.A.Flygare,
D.Vucic,
K.Deshayes,
W.J.Fairbrother,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
20.00 /
2.20
|
Space group
|
P 32
|
Cell size a, b, c (Å), α, β, γ (°)
|
82.770,
82.770,
93.170,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
16.9 /
22.5
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap)
(pdb code 1oxn). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 5 binding sites of Zinc where determined in the
Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap), PDB code: 1oxn:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
Zinc binding site 1 out
of 5 in 1oxn
Go back to
Zinc Binding Sites List in 1oxn
Zinc binding site 1 out
of 5 in the Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap)
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn1001
b:42.4
occ:1.00
|
NE2
|
A:HIS144
|
2.2
|
38.9
|
1.0
|
SG
|
A:CYS151
|
2.2
|
31.0
|
1.0
|
SG
|
A:CYS127
|
2.3
|
26.8
|
1.0
|
SG
|
A:CYS124
|
2.4
|
27.8
|
1.0
|
CB
|
A:CYS151
|
3.0
|
28.6
|
1.0
|
CE1
|
A:HIS144
|
3.0
|
34.5
|
1.0
|
CB
|
A:CYS124
|
3.1
|
19.5
|
1.0
|
CB
|
A:CYS127
|
3.1
|
24.0
|
1.0
|
CD2
|
A:HIS144
|
3.2
|
37.0
|
1.0
|
N
|
A:CYS127
|
3.5
|
23.7
|
1.0
|
CA
|
A:CYS127
|
3.9
|
28.6
|
1.0
|
ND1
|
A:HIS144
|
4.2
|
36.8
|
1.0
|
CG
|
A:HIS144
|
4.3
|
38.0
|
1.0
|
CA
|
A:CYS151
|
4.3
|
31.4
|
1.0
|
CB
|
A:PHE126
|
4.6
|
30.9
|
1.0
|
CA
|
A:CYS124
|
4.6
|
25.8
|
1.0
|
C
|
A:PHE126
|
4.7
|
28.6
|
1.0
|
CB
|
A:PHE148
|
4.7
|
27.9
|
1.0
|
C
|
A:CYS127
|
4.7
|
27.9
|
1.0
|
N
|
A:TYR128
|
4.8
|
26.6
|
1.0
|
CB
|
A:PHE153
|
4.9
|
35.4
|
1.0
|
N
|
A:PHE126
|
4.9
|
30.5
|
1.0
|
CA
|
A:PHE126
|
4.9
|
29.4
|
1.0
|
CB
|
A:LEU154
|
4.9
|
36.6
|
1.0
|
N
|
A:LEU154
|
4.9
|
37.0
|
1.0
|
|
Zinc binding site 2 out
of 5 in 1oxn
Go back to
Zinc Binding Sites List in 1oxn
Zinc binding site 2 out
of 5 in the Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap)
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn1002
b:26.4
occ:1.00
|
NE2
|
B:HIS144
|
2.1
|
20.7
|
1.0
|
SG
|
B:CYS151
|
2.2
|
17.2
|
1.0
|
SG
|
B:CYS127
|
2.3
|
17.1
|
1.0
|
SG
|
B:CYS124
|
2.4
|
18.5
|
1.0
|
CE1
|
B:HIS144
|
2.9
|
16.2
|
1.0
|
CB
|
B:CYS151
|
3.0
|
16.9
|
1.0
|
CB
|
B:CYS124
|
3.1
|
15.3
|
1.0
|
CD2
|
B:HIS144
|
3.2
|
17.3
|
1.0
|
CB
|
B:CYS127
|
3.2
|
14.7
|
1.0
|
N
|
B:CYS127
|
3.5
|
15.1
|
1.0
|
CA
|
B:CYS127
|
4.0
|
16.4
|
1.0
|
ND1
|
B:HIS144
|
4.1
|
18.8
|
1.0
|
CG
|
B:HIS144
|
4.2
|
14.3
|
1.0
|
CA
|
B:CYS151
|
4.4
|
18.8
|
1.0
|
CA
|
B:CYS124
|
4.5
|
18.4
|
1.0
|
CB
|
B:PHE126
|
4.6
|
17.1
|
1.0
|
C
|
B:PHE126
|
4.6
|
21.2
|
1.0
|
CB
|
B:PHE148
|
4.7
|
18.0
|
1.0
|
C
|
B:CYS127
|
4.8
|
19.2
|
1.0
|
CB
|
B:LEU154
|
4.8
|
16.8
|
1.0
|
N
|
B:PHE126
|
4.9
|
15.4
|
1.0
|
N
|
B:TYR128
|
4.9
|
18.7
|
1.0
|
CA
|
B:PHE126
|
4.9
|
18.3
|
1.0
|
N
|
B:LEU154
|
5.0
|
14.6
|
1.0
|
|
Zinc binding site 3 out
of 5 in 1oxn
Go back to
Zinc Binding Sites List in 1oxn
Zinc binding site 3 out
of 5 in the Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap)
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn1003
b:29.2
occ:1.00
|
NE2
|
C:HIS144
|
2.0
|
17.1
|
1.0
|
SG
|
C:CYS151
|
2.3
|
17.7
|
1.0
|
SG
|
C:CYS127
|
2.3
|
19.5
|
1.0
|
SG
|
C:CYS124
|
2.3
|
19.3
|
1.0
|
CE1
|
C:HIS144
|
2.8
|
18.7
|
1.0
|
CB
|
C:CYS151
|
3.1
|
15.3
|
1.0
|
CB
|
C:CYS124
|
3.1
|
16.8
|
1.0
|
CD2
|
C:HIS144
|
3.2
|
16.0
|
1.0
|
CB
|
C:CYS127
|
3.2
|
17.0
|
1.0
|
N
|
C:CYS127
|
3.6
|
17.7
|
1.0
|
ND1
|
C:HIS144
|
4.0
|
15.8
|
1.0
|
CA
|
C:CYS127
|
4.0
|
18.9
|
1.0
|
CG
|
C:HIS144
|
4.2
|
17.3
|
1.0
|
CA
|
C:CYS151
|
4.4
|
18.4
|
1.0
|
CA
|
C:CYS124
|
4.5
|
18.9
|
1.0
|
CB
|
C:PHE126
|
4.6
|
19.8
|
1.0
|
CB
|
C:PHE148
|
4.7
|
17.5
|
1.0
|
C
|
C:PHE126
|
4.7
|
19.6
|
1.0
|
C
|
C:CYS127
|
4.8
|
20.6
|
1.0
|
N
|
C:TYR128
|
4.8
|
21.1
|
1.0
|
CB
|
C:LEU154
|
4.9
|
17.7
|
1.0
|
N
|
C:PHE126
|
4.9
|
19.4
|
1.0
|
CA
|
C:PHE126
|
4.9
|
20.8
|
1.0
|
|
Zinc binding site 4 out
of 5 in 1oxn
Go back to
Zinc Binding Sites List in 1oxn
Zinc binding site 4 out
of 5 in the Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap)
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn1004
b:32.4
occ:1.00
|
NE2
|
D:HIS144
|
2.0
|
19.6
|
1.0
|
SG
|
D:CYS127
|
2.2
|
18.7
|
1.0
|
SG
|
D:CYS151
|
2.4
|
23.6
|
1.0
|
SG
|
D:CYS124
|
2.4
|
21.9
|
1.0
|
CE1
|
D:HIS144
|
2.9
|
21.5
|
1.0
|
CB
|
D:CYS124
|
3.0
|
15.9
|
1.0
|
CB
|
D:CYS151
|
3.1
|
19.0
|
1.0
|
CD2
|
D:HIS144
|
3.1
|
17.7
|
1.0
|
CB
|
D:CYS127
|
3.3
|
23.2
|
1.0
|
N
|
D:CYS127
|
3.5
|
19.9
|
1.0
|
CA
|
D:CYS127
|
4.0
|
22.5
|
1.0
|
ND1
|
D:HIS144
|
4.0
|
20.4
|
1.0
|
CG
|
D:HIS144
|
4.2
|
18.7
|
1.0
|
CA
|
D:CYS151
|
4.4
|
20.3
|
1.0
|
CB
|
D:PHE126
|
4.5
|
27.5
|
1.0
|
CA
|
D:CYS124
|
4.5
|
17.4
|
1.0
|
C
|
D:PHE126
|
4.6
|
21.3
|
1.0
|
CB
|
D:PHE148
|
4.7
|
27.4
|
1.0
|
C
|
D:CYS127
|
4.8
|
25.0
|
1.0
|
CA
|
D:PHE126
|
4.8
|
21.5
|
1.0
|
N
|
D:TYR128
|
4.9
|
24.4
|
1.0
|
N
|
D:PHE126
|
4.9
|
26.2
|
1.0
|
CB
|
D:LEU154
|
4.9
|
20.9
|
1.0
|
CD2
|
D:PHE148
|
4.9
|
27.7
|
1.0
|
|
Zinc binding site 5 out
of 5 in 1oxn
Go back to
Zinc Binding Sites List in 1oxn
Zinc binding site 5 out
of 5 in the Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap)
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:Zn1005
b:30.1
occ:1.00
|
NE2
|
E:HIS144
|
2.0
|
20.1
|
1.0
|
SG
|
E:CYS127
|
2.3
|
21.7
|
1.0
|
SG
|
E:CYS151
|
2.3
|
19.7
|
1.0
|
SG
|
E:CYS124
|
2.4
|
20.0
|
1.0
|
CE1
|
E:HIS144
|
2.8
|
20.0
|
1.0
|
CB
|
E:CYS124
|
3.0
|
13.5
|
1.0
|
CB
|
E:CYS151
|
3.0
|
22.5
|
1.0
|
CB
|
E:CYS127
|
3.2
|
20.0
|
1.0
|
CD2
|
E:HIS144
|
3.2
|
15.6
|
1.0
|
N
|
E:CYS127
|
3.5
|
17.2
|
1.0
|
CA
|
E:CYS127
|
3.9
|
21.8
|
1.0
|
ND1
|
E:HIS144
|
4.0
|
18.5
|
1.0
|
CG
|
E:HIS144
|
4.2
|
19.6
|
1.0
|
CA
|
E:CYS151
|
4.4
|
23.8
|
1.0
|
CA
|
E:CYS124
|
4.5
|
15.5
|
1.0
|
CB
|
E:PHE126
|
4.6
|
18.5
|
1.0
|
C
|
E:PHE126
|
4.6
|
17.0
|
1.0
|
C
|
E:CYS127
|
4.8
|
22.2
|
1.0
|
N
|
E:PHE126
|
4.8
|
19.9
|
1.0
|
CB
|
E:PHE148
|
4.8
|
24.2
|
1.0
|
CA
|
E:PHE126
|
4.8
|
17.8
|
1.0
|
N
|
E:TYR128
|
4.9
|
19.7
|
1.0
|
C
|
E:CYS124
|
4.9
|
17.5
|
1.0
|
|
Reference:
M.C.Franklin,
S.Kadkhodayan,
H.Ackerly,
D.Alexandru,
M.D.Distefano,
L.O.Elliott,
J.A.Flygare,
G.Mausisa,
D.C.Okawa,
D.Ong,
D.Vucic,
K.Deshayes,
W.J.Fairbrother.
Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (Ml-Iap) Biochemistry V. 42 8223 2003.
ISSN: ISSN 0006-2960
PubMed: 12846571
DOI: 10.1021/BI034227T
Page generated: Wed Oct 16 17:35:19 2024
|